Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melanoma models for the next generation of therapies
E. Elizabeth Patton, Kristen L. Mueller, David J. Adams, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 610-631
Open Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials
E. Elizabeth Patton, Leonard I. Zon, David M. Langenau
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 8, pp. 611-628
Open Access | Times Cited: 360
A cellular hierarchy in melanoma uncouples growth and metastasis
Panagiotis Karras, Ignacio Bordeu, Joanna Poźniak, et al.
Nature (2022) Vol. 610, Iss. 7930, pp. 190-198
Open Access | Times Cited: 152
Small molecule inhibitors targeting the cancers
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 87
The journey from melanocytes to melanoma
Patricia P. Centeno, Valeria Pavet, Richard Marais
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 372-390
Closed Access | Times Cited: 82
Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling
Radomir M. Slominski, Tae‐Kang Kim, Zorica Janjetović, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2262-2262
Open Access | Times Cited: 19
Orthotopic and metastatic tumour models in preclinical cancer research
Stephen M. Stribbling, Callum Beach, Anderson J. Ryan
Pharmacology & Therapeutics (2024) Vol. 257, pp. 108631-108631
Open Access | Times Cited: 17
Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
Tianchuan Zhu, Yuchen Xiao, Zhenxing Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells
Elisa Matas-Rico, Elselien Frijlink, Irene van der Haar Àvila, et al.
Cell Reports (2021) Vol. 37, Iss. 7, pp. 110013-110013
Open Access | Times Cited: 58
Stepwise-edited, human melanoma models reveal mutations’ effect on tumor and microenvironment
Eran Hodis, Elena Torlai Triglia, John Kwon, et al.
Science (2022) Vol. 376, Iss. 6592
Open Access | Times Cited: 48
Preclinical models for drug discovery for metastatic disease
Lalage M. Wakefield, Seema Agarwal, Kandice Tanner
Cell (2023) Vol. 186, Iss. 8, pp. 1792-1813
Closed Access | Times Cited: 29
Decoding the interplay between genetic and non-genetic drivers of metastasis
Panagiotis Karras, James R. Black, Nicholas McGranahan, et al.
Nature (2024) Vol. 629, Iss. 8012, pp. 543-554
Closed Access | Times Cited: 14
Coding, or non-coding, that is the question
Laura Poliseno, Martina Lanza, Pier Paolo Pandolfi
Cell Research (2024) Vol. 34, Iss. 9, pp. 609-629
Open Access | Times Cited: 14
Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research
Juliana Santos Rosa Viegas, Bruno Sarmento
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115295-115295
Open Access | Times Cited: 11
Mucosal Melanoma: Pathological Evolution, Pathway Dependency and Targeted Therapy
Yanni Ma, Ronghui Xia, Xuhui Ma, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 47
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma
Roberto Vendramin, Vicky Katopodi, Sonia Cinque, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 9
Open Access | Times Cited: 41
Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice
Anna Chen, Ines Neuwirth, Dietmar Herndler‐Brandstetter
Cancers (2023) Vol. 15, Iss. 11, pp. 2989-2989
Open Access | Times Cited: 17
A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options
Lulu Sun, Xindan Kang, Houyu Ju, et al.
Science Advances (2023) Vol. 9, Iss. 43
Open Access | Times Cited: 17
3D Spheroid Configurations Are Possible Indictors for Evaluating the Pathophysiology of Melanoma Cell Lines
Hiroshi Ohguro, Megumi Watanabe, Tatsuya Sato, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 759-759
Open Access | Times Cited: 16
Melanocyte lineage dynamics in development, growth and disease
Alessandro Brombin, E. Elizabeth Patton
Development (2024) Vol. 151, Iss. 15
Open Access | Times Cited: 7
Dormancy of cutaneous melanoma
Kathrin Singvogel, Birgit Schittek
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Tfap2b specifies an embryonic melanocyte stem cell that retains adult multifate potential
Alessandro Brombin, Daniel J. Simpson, Jana Trávníčková, et al.
Cell Reports (2022) Vol. 38, Iss. 2, pp. 110234-110234
Open Access | Times Cited: 24
Ibrutinib topical delivery for melanoma treatment: The effect of nanostructured lipid carriers’ composition on the controlled drug skin deposition
Lucas F. F. Albuquerque, Fernanda Vitelli Lins, Elizabete Cristina Iseke Bispo, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 237, pp. 113875-113875
Closed Access | Times Cited: 5
OBSERVE: guidelines for the refinement of rodent cancer models
Stéphanie I. De Vleeschauwer, Marieke van de Ven, Anaïs Oudin, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2571-2596
Closed Access | Times Cited: 5
Gold nanostructures in melanoma: Advances in treatment, diagnosis, and theranostic applications
Zahra Sadat Dastgheib, Samira Sadat Abolmaali, Ghazal Farahavar, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35655-e35655
Open Access | Times Cited: 5
Ferroptosis: A Targetable Vulnerability for Melanoma Treatment
Meng Yu, Qian Zhou, Yating Dian, et al.
Journal of Investigative Dermatology (2025)
Open Access
Page 1 - Next Page

Scroll to top